MedTrace Logo

Study of Barriers to Beginning and Finishing Treatment for Patients With Breast Cancer

NCT00937989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2015-06-08

No results posted yet for this study

Summary

RATIONALE: Gathering information about barriers to receiving breast cancer treatment may help doctors learn more about improving the treatment process and improve patients' quality of life.

PURPOSE: This clinical trial is studying barriers to beginning and finishing treatment for patients with breast cancer.

Conditions

Interventions

OTHER

educational intervention

Occurs weekly during the first 8 weeks of the study and thereafter a minimum of monthly through the 9th month of the study.

OTHER

informational intervention

Occurs weekly during the first 8 weeks of the study and thereafter a minimum of monthly through the 9th month of the study.

OTHER

medical chart review

Baseline, 3, 6 and 9 months after starting the study

OTHER

questionnaire administration

Baseline, 3, 6 and 9 months after starting the study

OTHER

study of socioeconomic and demographic variables

Baseline, 3, 6 and 9 months after starting the study

PROCEDURE

quality-of-life assessment

Baseline, 3, 6 and 9 months after starting the study

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Rebecca Crane-Okada, PhD · City of Hope Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-05-31
Completion
2011-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937989 on ClinicalTrials.gov